Search
-
Heterozygous pathogenic variants in POMC are not responsible for monogenic obesity: Implication for MC4R agonist use
(Genetics in Medicine. vol. 25, n° 7, 2023-07)Article de revueOpen access -
Endocannabinoid-related molecules predict the metabolic efficacy of GLP-1 receptor agonism in humans with obesity
(Journal of Endocrinological Investigation, 2023-11-04)Article de revue -
Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system.
(Multiple Sclerosis Journal. vol. 29, n° 2, pp. 236-247, 2023-02-01)Article de revue -
Neuropilin-1 expression in GnRH neurons regulates prepubertal weight gain and sexual attraction
(EMBO Journal. vol. 39, n° 19, 2020-10-01)Article de revueOpen access -
Spinal Inhibition of GABAB Receptors by the Extracellular Matrix Protein Fibulin-2 in Neuropathic Rats
(Frontiers in Cellular Neuroscience. vol. 14, n° 214, 2020-07-15)Article de revueOpen access -
L’exercice physique pour la santé mentale : mécanismes, recommandations, recherches futures
(Encephale. vol. 49, n° 3, pp. 296-303, 2023-06)Article de revue -
Persistent cortisol response to desmopressin predicts recurrence of Cushing's disease in patients with post-operative corticotropic insufficiency
(European Journal of Endocrinology. vol. 182, n° 5, pp. 489-498, 2020-05)Article de revue -
Expression of Functional Cannabinoid Type-1 (CB1) Receptor in Mitochondria of White Adipocytes
(Cells. vol. 11, n° 16, pp. 2582, 2022-08-19)Article de revueOpen access -
NOS1 mutations cause hypogonadotropic hypogonadism with sensory and cognitive deficits that can be reversed in infantile mice
(Science Translational Medicine. vol. 14, n° 665, 2022-10-05)Article de revueOpen access -
Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing–Remitting Multiple Sclerosis After Fingolimod Withdrawal
(Neurotherapeutics. vol. 19, n° 2, pp. 476-490, 2022-03)Article de revueOpen access